Skip to content
Recall Observatory FDA recall evidence

Drug product

Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11

D-1257-2020

April 18, 2020

Class I

Product summary

Firm
B. Braun Medical Inc
Event
Event 85507
Status
Terminated
Classification
Class I
Quantity
22,488 Duplex containers
Official record key
drug-enforcement:D-1257-2020

Official wording

Reason: Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.

Code information: Lot #: H8J812, Exp. Date 31 JUL 2020

Distribution pattern: Product was distributed nationwide within the United States.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-Specification